• HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
Friday, November 20, 2026
BIOENGINEER.ORG
No Result
View All Result
  • Login
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
No Result
View All Result
Bioengineer.org
No Result
View All Result
Home NEWS Science News Health

Transcriptomic Analysis Examines Autophagy Signatures in Tuberculosis and Diabetes Comorbidity

by
November 6, 2026
in Health
Reading Time: 2 mins read
0
Transcriptomic Analysis Examines Autophagy Signatures in Tuberculosis and Diabetes Comorbidity

Transcriptomic Analysis Examines Autophagy Signatures in Tuberculosis and Diabetes Comorbidity

Share on FacebookShare on TwitterShare on LinkedinShare on RedditShare on Telegram

An exploratory multi-dataset transcriptomic analysis of tuberculosis-diabetes comorbidity has revealed that host autophagy-related transcriptional alterations are predominantly associated with tuberculosis status rather than a specific disease interaction. In the study, a total of 310 autophagy-related genes were differentially expressed when comparing individuals with both tuberculosis and diabetes to healthy controls, comprising 175 up-regulated genes and 135 down-regulated genes. However, direct comparisons and a formal interaction test demonstrated that none of the prioritised genes distinguished patients with both conditions from those with tuberculosis alone, and no gene showed a statistically significant interaction after multiple-testing correction.

The investigation addressed the transcriptional organisation of autophagy-related genes in comorbidity, where tuberculosis and diabetes co-occurrence is associated with altered host immunity and poorer clinical outcomes. While autophagy is relevant to intracellular mycobacterial control, its transcriptional patterns in this dual-disease context remained incompletely defined. To investigate these profiles, researchers compiled autophagy-related genes using the Gene Ontology autophagy term and its descendants, creating a focused framework to assess expression changes across publicly available data.

The analytical design relied on public transcriptomic datasets related to tuberculosis-diabetes comorbidity, centered on the primary discovery set GSE114192. This primary cohort included 61 individuals with tuberculosis-diabetes comorbidity, 46 with tuberculosis alone, 52 with diabetes alone, and 36 healthy controls. In addition, datasets representing drug-resistant tuberculosis and lesion tissue were evaluated strictly as complementary, cross-context resources rather than as directly matched comorbidity cohorts or validation populations.

Across the comparative analyses, 253 autophagy-related genes were altered in the tuberculosis-only group relative to controls, 139 were altered in the diabetes-only comparison, and 78 genes were shared across all three evaluated disease groups. Protein interaction analysis of the prioritised genes uncovered a connected network of 196 interactions among 60 genes, where MTOR, GABARAPL2, BCL2, RPTOR, ATG7, and ATG3 emerged as the most central nodes. Pathway enrichment analysis was dominated by canonical autophagy, mitophagy, lysosome, and mTOR-related terms. Furthermore, a logistic classification model constructed using autophagy genes selected under nested cross-validation achieved an area under the receiver operating characteristic curve of 0.974, with a 95 percent confidence interval ranging from 0.946 to 0.993.

Despite the high performance within the discovery data, the logistic model demonstrated substantial limitations when tested across different tissue contexts. When applied to an independent pulmonary-lesion dataset, the model showed no discriminative transfer, recording an area under the receiver operating characteristic curve of only 0.558 and confirming that the model should not be regarded as validated across tissues. The authors concluded that their findings establish a hypothesis-generating framework for host-directed investigations in diabetes-associated tuberculosis while identifying a coherent autophagy-related transcriptional programme that requires orthogonal experimental validation.

Subject of Research: Host autophagy-related transcriptional signatures in tuberculosis-diabetes comorbidity

Article Title: Host autophagy-related transcriptional signatures in tuberculosis-diabetes comorbidity: an exploratory multi-dataset transcriptomic analysis

Article References: Lu, Y. (2026). Host autophagy-related transcriptional signatures in tuberculosis-diabetes comorbidity: an exploratory multi-dataset transcriptomic analysis. BMC Infectious Diseases. https://doi.org/10.1186/s12879-026-14669-6

Image Credits: AI Generated

DOI: 10.1186/s12879-026-14669-6

Keywords: tuberculosis, diabetes, comorbidity, autophagy, transcriptomics, gene expression, MTOR, biomarkers, Host, autophagy-related, transcriptional, signatures

News Source: Juliet Wilcox. (November 6, 2026). Transcriptomic Analysis Examines Autophagy Signatures in Tuberculosis and Diabetes Comorbidity. Scienmag.

Tags: autophagyAutophagy-relatedbiomarkersComorbidityDiabetesgene expressionhostmTORsignaturestranscriptionalTranscriptomicsTuberculosis
Share12Tweet7Share2ShareShareShare1

Related Posts

Review Outlines Anesthetic Strategies and Perioperative Risks in Systemic Lupus Erythematosus

Review Outlines Anesthetic Strategies and Perioperative Risks in Systemic Lupus Erythematosus

November 20, 2026
Fatal Cardiomyopathy Progressed in Lipodystrophy Patient Despite Metreleptin Therapy

Fatal Cardiomyopathy Progressed in Lipodystrophy Patient Despite Metreleptin Therapy

November 20, 2026

Immune Risk Phenotype Predicts Long-Term Mortality Following Pneumonia in Older Adults

November 20, 2026

Review Clarifies Vasoactive Drug Selection for Patients on Venoarterial ECMO Support

November 20, 2026

POPULAR NEWS

  • Narrative Review Explores Shared Biological Pathways Linking Obesity and Migraine Progression

    Narrative Review Explores Shared Biological Pathways Linking Obesity and Migraine Progression

    29 shares
    Share 12 Tweet 7
  • Semaglutide Preserves Muscle Function and Boosts Running Capacity in Obese Mice

    29 shares
    Share 12 Tweet 7
  • Millet Field Trials in Côte d’Ivoire Reveal Elite High-Yielding Local Landraces

    29 shares
    Share 12 Tweet 7
  • Survey Links Software AI Use to Governance Deficits and Training Gaps

    29 shares
    Share 12 Tweet 7

About

We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.

Follow us

Recent News

Veterinary Specialists Release First Comprehensive Diagnostic Imaging Reference for Nondomestic Mammals

Review Outlines Anesthetic Strategies and Perioperative Risks in Systemic Lupus Erythematosus

Review Details AI Integration and Structural Trade-Offs in Autonomous Drone Design

Subscribe to Blog via Email

Enter your email address to subscribe to this blog and receive notifications of new posts by email.

Join 89 other subscribers
  • Contact Us

Bioengineer.org © Copyright 2023 All Rights Reserved.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • Homepages
    • Home Page 1
    • Home Page 2
  • News
  • National
  • Business
  • Health
  • Lifestyle
  • Science

Bioengineer.org © Copyright 2023 All Rights Reserved.